Quick Answer
CorMedix Inc. reported Operating Income of $150.14 million for fiscal year 2025.
CorMedix Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | $150.14M | +771.6% |
| 2024 | -$22.36M | +54.3% |
| 2023 | -$48.96M | -59.9% |
| 2022 | -$30.62M | -4.0% |
| 2021 | -$29.44M | -8.1% |
| 2020 | -$27.22M | -29.6% |
| 2019 | -$21.01M | +21.8% |
| 2018 | -$26.86M | +18.4% |
| 2017 | -$32.92M | -33.0% |
| 2016 | -$24.76M | -48.7% |
| 2015 | -$16.65M | -87.1% |
| 2014 | -$8.90M | -81.1% |
| 2013 | -$4.92M | -63.9% |
| 2012 | -$3.00M | +58.6% |
| 2011 | -$7.25M | +14.8% |
| 2010 | -$8.51M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $51.35M | +1661.9% | +162.7% |
| June 30, 2025 | $19.54M | +227.7% | -2.9% |
| March 31, 2025 | $20.13M | +220.5% | +712.2% |
| September 30, 2024 | -$3.29M | +68.6% | +78.5% |
| June 30, 2024 | -$15.30M | -29.6% | +8.4% |
| March 31, 2024 | -$16.70M | -51.6% | -59.6% |
| September 30, 2023 | -$10.47M | -50.4% | +11.3% |
| June 30, 2023 | -$11.80M | -43.3% | -7.1% |
- CorMedix Inc. showed an increase of +771.6% in Operating Income compared to the prior fiscal year.
- Over the 2010–2025 period, CorMedix Inc.’s operating income has grown by 1864.9% (from -$8.51 million to $150.14 million).
- The most recent figure is from CorMedix Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: